Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Topical Bevacizumab for Preventing Recurrent Pterygium

This study has been completed.
Information provided by (Responsible Party):
Ngamjit Kasetsuwan, Chulalongkorn University Identifier:
First received: December 1, 2010
Last updated: April 6, 2013
Last verified: March 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2013
  Primary Completion Date: March 2013 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):